Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $188.70 million. The enterprise value is $175.79 million.

Market Cap	188.70M
Enterprise Value	175.79M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

CADL has 29.35 million shares outstanding. The number of shares has increased by 0.39% in one year.

Shares Outstanding	29.35M
Shares Change (YoY)	+0.39%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	34.72%
Owned by Institutions (%)	16.46%
Float	18.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	14.81
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 1.79.

Current Ratio	2.59
Quick Ratio	n/a
Debt / Equity	1.79
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.62

Financial Efficiency

Return on equity (ROE) is -142.90% and return on invested capital (ROIC) is -108.12%.

Return on Equity (ROE)	-142.90%
Return on Assets (ROA)	-69.90%
Return on Capital (ROIC)	-108.12%
Revenue Per Employee	n/a
Profits Per Employee	-$903,310
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +360.71% in the last 52 weeks. The beta is 0.92, so CADL's price volatility has been similar to the market average.

Beta (1Y)	0.92
52-Week Price Change	+360.71%
50-Day Moving Average	3.02
200-Day Moving Average	1.59
Relative Strength Index (RSI)	66.55
Average Volume (30 Days)	5,366,040

Short Selling Information

The latest short interest is 2.03 million, so 6.91% of the outstanding shares have been sold short.

Short Interest	2.03M
Short Previous Month	160,915
Short % of Shares Out	6.91%
Short % of Float	11.24%
Short Ratio (days to cover)	2.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.39M
Pretax Income	-37.94M
Net Income	-37.94M
EBITDA	-34.14M
EBIT	-35.34M
Earnings Per Share (EPS)	-$1.31

Full Income Statement

Balance Sheet

The company has $35.68 million in cash and $22.76 million in debt, giving a net cash position of $12.92 million or $0.44 per share.

Cash & Cash Equivalents	35.68M
Total Debt	22.76M
Net Cash	12.92M
Net Cash Per Share	$0.44
Equity / Book Value	12.75M
Book Value Per Share	0.43
Working Capital	22.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.24 million and capital expenditures -$280,000, giving a free cash flow of -$34.52 million.

Operating Cash Flow	-34.24M
Capital Expenditures	-280,000
Free Cash Flow	-34.52M
FCF Per Share	-$1.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.39%
Shareholder Yield	-0.39%
Earnings Yield	-20.10%
FCF Yield	-18.30%

Analyst Forecast

The average price target for CADL is $7.00, which is 8.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	8.87%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2